Diclofenac Sodium/Misoprostol

FDA Drug Profile — Diclofenac Sodium/Misoprostol DICLOFENAC-SODIUM-MISOPROSTOL

Diclofenac Sodium/Misoprostol is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Diclofenac Sodium/Misoprostol DICLOFENAC-SODIUM-MISOPROSTOL. Available dosage form: tablet.

Drug details

Generic Name
Diclofenac Sodium/Misoprostol
Brand Names
Diclofenac Sodium/Misoprostol DICLOFENAC-SODIUM-MISOPROSTOL
Application Number
ANDA204355
Sponsor
Micro Labs Limited
NDC Codes
4
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
DICLOFENAC SODIUM, MISOPROSTOL

Indications and Usage

1 INDICATIONS AND USAGE Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions ( 5.3 )] . Diclofenac sodium and misoprostol delayed-release tablets are a combination of diclofenac sodium, a non-steroidal anti-inflammatory drug, and misoprostol, a prostaglandin-1 (PGE1) analog, indicated for the treatment of signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.